Ryan C. Holcomb,Kazuyuki Suzuki,Robert J. Halter,Paul R. Sebahar,Donald A. McLeod,Mark D. Shenderovich,Kraig M. Yager,Matthew Gregory Bursavich,Ashantai J. Yungai,Burt Richards,Paul L. Bartel,Daniel A
申请号：
US14581065
公开号：
US20150352108A1
申请日:
2014.12.23
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
